Embla Medical Signs Agreement to Invest in a Majority Share in Streifeneder Ortho.production GmbH
Streifeneder is an international developer and supplier of orthopaedic mobility solutions, employing around 100 people.
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Streifeneder is an international developer and supplier of orthopaedic mobility solutions, employing around 100 people.
The Series B financing will support the initiation of the company’s pivotal VERITAS trial, advance the FieldForce Ablation System development, and further expand Field Medical’s clinical and regulatory capabilities.
Breakthrough proteomics platform technology unlocks full-length protein sequencing and characterisation, accelerating drug development and diagnostics